Chemo Pharma Laboratories Share Price
₹110.59 +2.99 (2.78%)
28 Dec, 2024 15:54
Start SIP in CHEMOPH
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 41%
- Over 3 Month + 60.25%
- Over 6 Month + 60.39%
- Over 1 Year + 84.32%
Smart Investing Starts Here Start SIP with Chemo Pharma Laboratories for Steady Growth!
Chemo Pharma Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Chemo Pharma Laboratories Financials
Chemo Pharma Laboratories Technicals
EMA & SMA
Current Price
₹110.59
+
2.99
(2.78%)
- Bullish Moving Average 16
- Bearish Moving Average 0
- 20 Day
- ₹102.46
- 50 Day
- ₹92.28
- 100 Day
- ₹83.69
- 200 Day
- ₹75.07
Resistance and Support
108.1
- R3 120.74
- R2 115.70
- R1 113.14
- S1 105.54
- S2 100.50
- S3 97.94
Chemo Pharma Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-10-28 | Quarterly Results | |
2024-07-29 | Quarterly Results & A.G.M. | |
2024-05-27 | Audited Results | |
2024-01-29 | Quarterly Results & Others | Inter alia, to consider and approve the Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24. |
2023-10-27 | Quarterly Results |
Chemo Pharma Laboratories F&O
About Chemo Pharma Laboratories
- NSE Symbol
- CHEMOPH
- BSE Symbol
- 506365
- ISIN
- INE320M01019
Similar Stocks to Chemo Pharma Laboratories
Chemo Pharma Laboratories FAQs
Chemo Pharma Laboratories share price is ₹110 As on 28 December, 2024 | 15:40
The Market Cap of Chemo Pharma Laboratories is ₹16.6 Cr As on 28 December, 2024 | 15:40
The P/E ratio of Chemo Pharma Laboratories is 13.4 As on 28 December, 2024 | 15:40
The PB ratio of Chemo Pharma Laboratories is 1.3 As on 28 December, 2024 | 15:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.